HEPACAM and myeloid sarcoma: Clonally expanded antibodies isolated from the cerebrospinal fluid of MS patients target EBNA‐1 residues 386–405 that cross‐react with the CNS cell adhesion molecule GlialCAM and are associated with CD4 and CD8 T cell responses targeting GlialCAM.